To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Latest action · Jan 16, 2009 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 15, 2009
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.
Cosponsors 3
Members who signed on, in the order they did. All signed on Jan 15, 2009.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-KS | Dennis Moore | Original | Jan 15, 2009 |
| D-AR | Marion Berry | Original | Jan 15, 2009 |
| R-TN | Zach Wamp | Original | Jan 15, 2009 |
Actions 3
Everything that happened, newest first.
- Jan 16, 2009Referred to the Subcommittee on Health.
- Jan 15, 2009Introduced in House
- Jan 15, 2009Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jan 15, 2009Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.